Theravance Biopharma Current Deferred Revenue (Quarterly) Trends

Theravance Biopharma, Inc. (TBPH)

18.86 +0.15 (+0.80%) USD | NASDAQ | Dec 30, 16:00

18.86 0.00 (0.00%) After-Hours: 20:00

View Current Deferred Revenue (Quarterly) for TBPH.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Corcept Therapeutics, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Skye Bioscience, Inc.	--
FibroGen, Inc.	Upgrade
Myomo, Inc.	Upgrade